254 related articles for article (PubMed ID: 37577378)
1. Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by
Kulecka M; Zeber-Lubecka N; Bałabas A; Czarnowski P; Bagińska K; Głowienka M; Kluska A; Piątkowska M; Dąbrowska M; Waker E; Mikula M; Ostrowski J
Front Cell Infect Microbiol; 2023; 13():1190910. PubMed ID: 37577378
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiome and mycobiome in inflammatory bowel disease patients with
Yu S; Ge X; Xu H; Tan B; Tian B; Shi Y; Dai Y; Li Y; Hu S; Qian J
Front Cell Infect Microbiol; 2023; 13():1129043. PubMed ID: 36814443
[TBL] [Abstract][Full Text] [Related]
3. Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection.
Sokol H; Jegou S; McQuitty C; Straub M; Leducq V; Landman C; Kirchgesner J; Le Gall G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Richard ML; Beaugerie L
Gut Microbes; 2018 Jan; 9(1):55-60. PubMed ID: 28786749
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
Lin CY; Cheng HT; Kuo CJ; Lee YS; Sung CM; Keidan M; Rao K; Kao JY; Hsieh SY
Microbiol Spectr; 2022 Aug; 10(4):e0048622. PubMed ID: 35863023
[TBL] [Abstract][Full Text] [Related]
5. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
[TBL] [Abstract][Full Text] [Related]
6.
Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
[TBL] [Abstract][Full Text] [Related]
7. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
9. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
[TBL] [Abstract][Full Text] [Related]
11. [
Lee MR; Kim ES
Korean J Gastroenterol; 2022 Aug; 80(2):66-71. PubMed ID: 36004633
[TBL] [Abstract][Full Text] [Related]
12. Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease.
Bushman FD; Conrad M; Ren Y; Zhao C; Gu C; Petucci C; Kim MS; Abbas A; Downes KJ; Devas N; Mattei LM; Breton J; Kelsen J; Marakos S; Galgano A; Kachelries K; Erlichman J; Hart JL; Moraskie M; Kim D; Zhang H; Hofstaedter CE; Wu GD; Lewis JD; Zackular JP; Li H; Bittinger K; Baldassano R
Cell Host Microbe; 2020 Sep; 28(3):422-433.e7. PubMed ID: 32822584
[TBL] [Abstract][Full Text] [Related]
13. Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection.
Herrera G; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
Microbiol Spectr; 2022 Oct; 10(5):e0050222. PubMed ID: 36154277
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
[TBL] [Abstract][Full Text] [Related]
17. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.
Antharam VC; Li EC; Ishmael A; Sharma A; Mai V; Rand KH; Wang GP
J Clin Microbiol; 2013 Sep; 51(9):2884-92. PubMed ID: 23804381
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
[TBL] [Abstract][Full Text] [Related]
19. Metagenome-assembled genomes (MAGs) suggest an acetate-driven protective role in gut microbiota disrupted by Clostridioides difficile.
Herrera G; Castañeda S; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
Microbiol Res; 2024 Aug; 285():127739. PubMed ID: 38763016
[TBL] [Abstract][Full Text] [Related]
20. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
Schubert AM; Rogers MA; Ring C; Mogle J; Petrosino JP; Young VB; Aronoff DM; Schloss PD
mBio; 2014 May; 5(3):e01021-14. PubMed ID: 24803517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
